Focus on Patients

  1. FDA Further Expands And Clarifies Expanded Access FAQs 12/29/2025

    Healthcare attorney Dianne J. Bourque breaks down the FDA's October 2025 update to its Expanded Access FAQs.

  2. Most Ex-U.S. Countries Can't Access The Medicines They Help Study 12/19/2025

    When a country hosts a clinical trial, we assume patients there will eventually benefit from the therapy they helped test. Research Jennifer E. Miller, Ph.D., says that's not often the case.

  3. The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity 12/10/2025

    Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry. 

  4. Takeda Keeps Patients The Focus Of PDTs For Rare Disease 12/9/2025

    Takeda’s Kristina Allikmets, MD, Ph.D, shares how her team incorporates patient voices and prioritizes innovations to reduce treatment burden, expand access, and develop plasma-derived therapies for rare diseases.

  5. Designing Patient-Centric Recruitment Pathways With Real-Time Adherence Insights 12/8/2025

    Learn how digital adherence solutions can enable real-time monitoring and site-level oversight to improve patient engagement and protocol compliance.

  6. Patient Input Is A Must — Even Under Time And Money Constraints 12/4/2025

    Stacie J. Bell, PhD, chief clinical research officer of Lupus Therapeutics, discusses the positive impacts patient advocacy groups can have on patient recruitment, patient retention, protocol design, and more.

  7. Digital Biomarkers Are Reshaping Alzheimer's Patient Experience And Data 11/26/2025

    Cognito CEO Christian Howell shares how EEG and digital biomarkers are reshaping recruitment, patient experience, and the quality of study data in Alzheimer’s research.

  8. LinkedIn Message Leads To Advocate-Pharma Pursuit Of Expanded Access 11/21/2025

    Medicus Pharma CEO Raza Bokhari, MD and Gorlin Syndrome Alliance Executive Director Meredith Weiss describe how the two a partnering to match Medicus’ noninvasive treatment for basal cell carcinoma with GSA’s patient community.

  9. Ashvattha Therapeutics Shows Real-World Focus With subQ, Bilateral Dosing For Ophthalmology Drug 11/21/2025

    Ashvattha Therapeutics shows how keeping communication open with the ophthalmic community, investigators, and KOLs can lead to a study balanced by innovation and practicality.

  10. 'ONE In A MILLION' Aims To Bridge The Equity Gap In Clinical Trials 11/20/2025

    Tigerlily Foundation is launching its "ONE in a MILLION" national public-private partnership to engage one million people in high-risk communities with clinical research.